Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-23

Clinical Trial Update: OPTIMA-TBI Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial for Mild Traumatic Brain Injury (OPTIMA-TBI) was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Mild Traumatic Brain Injury | Phase 2 | Status: TERMINATED | Results posted: 2023-05-23